Literature DB >> 7934937

Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot.

M Finken1, P Kirschner, A Meier, A Wrede, E C Böttger.   

Abstract

Multidrug-resistant strains of Mycobacterium tuberculosis have resulted in several recent outbreaks. Recognition of drug resistance is important both for treatment and to prevent further transmission. Here we use molecular biology techniques to study the basis of streptomycin resistance in single and multidrug-resistant M. tuberculosis. We demonstrate that streptomycin resistance is associated with mutations implicated in ribosomal resistance. The mutations found either lead to amino acid changes in ribosomal protein S12 or alter the primary structure of the 16S rRNA. The 16S rRNA region mutated perturbs a pseudoknot structure in a region which has been linked to ribosomal S12 protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7934937     DOI: 10.1111/j.1365-2958.1993.tb01253.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  97 in total

1.  Novel approach for improving the productivity of antibiotic-producing strains by inducing combined resistant mutations.

Authors:  H Hu; K Ochi
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

2.  Structural basis for selectivity and toxicity of ribosomal antibiotics.

Authors:  E C Böttger; B Springer; T Prammananan; Y Kidan; P Sander
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

3.  Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay.

Authors:  K Hirano; C Abe; M Takahashi
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

4.  Fitness cost of chromosomal drug resistance-conferring mutations.

Authors:  Peter Sander; Burkhard Springer; Therdsak Prammananan; Antje Sturmfels; Martin Kappler; Michel Pletschette; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 5.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

6.  Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.

Authors:  S Sreevatsan; K E Stockbauer; X Pan; B N Kreiswirth; S L Moghazeh; W R Jacobs; A Telenti; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 7.  Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis.

Authors:  A Telenti
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

8.  Identification of the RsmG methyltransferase target as 16S rRNA nucleotide G527 and characterization of Bacillus subtilis rsmG mutants.

Authors:  Kenji Nishimura; Shanna K Johansen; Takashi Inaoka; Takeshi Hosaka; Shinji Tokuyama; Yasutaka Tahara; Susumu Okamoto; Fujio Kawamura; Stephen Douthwaite; Kozo Ochi
Journal:  J Bacteriol       Date:  2007-06-15       Impact factor: 3.490

9.  Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.

Authors:  Hum Nath Jnawali; Heekyung Yoo; Sungweon Ryoo; Kwang-Jun Lee; Bum-Joon Kim; Won-Jung Koh; Chang-Ki Kim; Hee-Jin Kim; Young Kil Park
Journal:  World J Microbiol Biotechnol       Date:  2013-01-18       Impact factor: 3.312

10.  Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR.

Authors:  A C Whelen; T A Felmlee; J M Hunt; D L Williams; G D Roberts; L Stockman; D H Persing
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.